PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252672
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1252672
HLA Typing Market size was valued at USD 1,997.3 Million in 2022, expanding at a CAGR of 6.8% from 2023 to 2030.
HLA typing is commonly used in medical settings, such as before an organ transplant, to match the donor and recipient HLA types as closely as possible to reduce the risk of rejection. It is also used in the diagnosis and management of autoimmune diseases, such as rheumatoid arthritis, and in determining susceptibility to certain infections or diseases.
The HLA typing market growth is mainly driven by the rising need for organ transplantation and the widespread use of human leukocyte antigen (HLA) testing in pharmacogenetics. The demand for HLA typing rises along with the amount of organ transplant surgeries. To reduce the risk of transplant rejection, HLA typing is crucial for determining the best possible match between the donor and recipient. Further, growing prevalence of autoimmune disease is also contributing to market growth. The prevalence of autoimmune diseases is on the rise, and HLA typing plays a critical role in their diagnosis and treatment. With the increasing incidence of autoimmune diseases, the demand for HLA typing is also increasing.
Furthermore, technological advancements in the field of HLA typing, such as the development of high-throughput sequencing methods, have significantly improved the accuracy and speed of the HLA typing process. These advancements have made HLA typing more accessible and affordable, thereby driving market growth. In addition, increasing government initiatives are boosting the market growth. Governments worldwide are implementing initiatives to promote organ donation and transplantation, which is expected to increase the demand for HLA typing. For instance, in the US, the National Organ Transplant Act was passed in 1984 to increase organ donation rates and provide more opportunities for organ transplantation.
The Global HLA Typing Market is segmented on the basis of Product, Application, End User, and Region.
The market is divided into three categories based on Product: instruments, reagents, and software & services. The reagents segment dominates the market. The increasing demand for reagents from diagnostic kits is mainly contributing to segment growth.
The market is divided into two categories based on Application: diagnosis and research. The diagnosis segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the demand for HLA typing in in diagnosis treatments.
The market is divided into three categories based on End User: commercial service providers, hospitals, and research labs. The hospitals segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increasing demand for HLA Typing in hospitals and transplant healthcare centers.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
North America held the largest market share in 2021 and is projected to continue its dominance during the forecast period. The rising demand for HLA Typing from hospitals sector is contributing to market growth.
Due to the constant development in HLA Typing market in the coming years, the worldwide market for HLA Typing is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, Products making, end user, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in March 2022, NeoGenomics Laboratories announced receiving U.S. FDA for using HLA typing for companion diagnostics.
This proposed research study on HLA Typing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for HLA Typing market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the HLA Typing market
Impact of COVID-19 on HLA Typing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on HLA Typing market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the HLA Typing market, we have also included competitive landscape and key innovator analysis for the HLA Typing market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the HLA Typing market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global HLA Typing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
The scope of this report covers the market by its major segments, which include as follows:
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories Inc.
Qiagen N.V.
Omixon Inc.
GenDx
Illumina Inc.
TBG Diagnostics Limited
Dickinson and Company
CareDx Inc.
Immucor, Inc.
Luminex Corporation
Hologic Inc.
Creative Biolabs
Takara Bio Inc.
F. Hoffman-La Roche Limited
Pacific Biosciences
Instruments
Reagents
Software & services
Diagnosis
Research
GLOBAL HLA TYPING MARKET, BY END USER
Commercial service providers
Hospitals
Research labs
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA